Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Matthieu Prot
Etienne Simon-Loriere
Xavier Montagutelli
Date of Patent
September 19, 2023
Patent Application Number
17819187
Date Filed
August 11, 2022
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 coronavirus Spike (S) protein antigen or a fragment thereof comprising the receptor-binding domain, wherein the nucleic acid construct sequence is codon-optimized for expression in human.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
